Otago Exercise Program in Chemotherapy Induced Peripheral Neuropathy
Impact of Otago Exercise Program on Muscle Weakness in Patients With Chemotherapy Induced Peripheral Neuropathy
1 other identifier
interventional
48
1 country
1
Brief Summary
Forty-eight participants between the age of 35 to 55years patient treated with Taxane chemotherapy, will be randomly divided into two equal groups, each comprising 24 patients.
- Group (A): Consists of twenty- four patients have chemo therapy Induced peripheral Neuropathy and will receive Otago exercise plus resistance exercise 3times per week for 8weeks
- Group (B): Consists of twenty- four patients with Chemotherapy induced peripheral Neuropathy who will receive conventional physical therapy program including: resistance exercise for 8weeks , 3 times per week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 15, 2026
CompletedFirst Posted
Study publicly available on registry
August 19, 2026
CompletedAugust 19, 2026
August 1, 2026
2 months
August 15, 2026
August 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle strength of the lower limb muscles will be assessed using a Hand-Held Dynamometer (HHD).
Muscle strength of the lower limb muscles will be assessed using a Hand-Held Dynamometer (HHD).
Baseline and after 8 weeks
Secondary Outcomes (1)
Modified Total Neuropathy Score (mTNS)
Baseline and after 8 weeks
Study Arms (2)
Otago Exercise Plus Resistance Exercise
EXPERIMENTALParticipants will receive the Otago Exercise Program in addition to resistance exercises using elastic bands, three sessions per week for 8 weeks.
Resistance exercises
ACTIVE COMPARATORParticipants will receive a conventional physical therapy program including resistance exercises with elastic bands, strengthening exercises, and lower limb exercises, three sessions per week for 8 weeks.
Interventions
An individualized Otago Exercise Program including warm-up, lower limb strengthening, balance, walking, and flexibility exercises. The program is delivered three times per week for 8 weeks under the supervision of a physical therapist.
resistance exercises with elastic bands, strengthening exercises, and lower limb exercises, three sessions per week for 8 weeks.
Eligibility Criteria
You may qualify if:
- Adults aged 35-55 years. Patients undergoing taxane chemotherapy. Diagnosed with chemotherapy-induced peripheral neuropathy (CIPN). Able to understand and follow assessment and treatment instructions. Willing to provide written informed consent.
You may not qualify if:
- Pre-existing neurological disorders (e.g., multiple sclerosis, stroke, or Parkinson's disease).
- Symptomatic heart disease, including congestive heart failure, arrhythmia, or myocardial infarction within the previous 3 months.
- Severe orthopedic conditions, fractures, or chronic debilitating diseases limiting participation in the exercise program.
- Psychological, cognitive, or emotional disorders affecting participation. Uncooperative patients or those unable to follow the exercise protocol. Refusal or inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
1 Gamma street ,Giza, Egypt -postal code:12613
Giza, Egypt, 12613, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cairo University
faculty of physical therapy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist
Study Record Dates
First Submitted
August 15, 2026
First Posted
August 19, 2026
Study Start
January 1, 2026
Primary Completion
March 1, 2026
Study Completion
April 1, 2026
Last Updated
August 19, 2026
Record last verified: 2026-08